Anmelden

A steady state refers to the level of a drug in the body once it has reached an equilibrium between administration and elimination. It represents the point at which the drug administration rate equals the drug elimination rate, resulting in a relatively constant concentration in the body over time. The dynamic equilibrium is crucial to ensure the drug's effectiveness with minimal risk of toxicity.

Most drugs are administered in repeated doses at fixed intervals or through continuous intravenous infusions to achieve a steady state. After each dose, the drug is absorbed, distributed, metabolized, and eliminated from the body. As subsequent doses are administered, the drug accumulates until the amount eliminated from the body in each dosing interval matches the amount administered. This leads to a stable concentration being maintained within a predictable range.

The rate at which a drug reaches a steady state depends on its half-life, which is the time it takes for the body to eliminate half of the drug. A drug typically takes around four to five half-lives to reach a steady state. During this time, the drug concentration gradually increases until it reaches a plateau where the administration and elimination rates become equal.

Once a steady state is achieved, the drug's concentration fluctuates within a narrow therapeutic range, ensuring a consistent pharmacological effect. Deviations from the steady-state concentration may lead to suboptimal treatment or increased risk of adverse effects. Factors such as patient characteristics, drug interactions, and changes in drug clearance should be considered when determining the optimal dosing strategy to achieve and maintain a steady state.

Tags
Steady State ConcentrationDrug AdministrationDrug EliminationDynamic EquilibriumDrug Half lifePharmacological EffectTherapeutic RangeDosing StrategyDrug InteractionsDrug Clearance

Aus Kapitel 3:

article

Now Playing

3.25 : Steady State Concentration

Pharmacokinetics

4.0K Ansichten

article

3.1 : Pharmakokinetik: Überblick

Pharmacokinetics

4.7K Ansichten

article

3.2 : Absorptionsmechanismus von Medikamenten: Passiver Membrantransport

Pharmacokinetics

3.2K Ansichten

article

3.3 : Absorptionsmechanismus von Medikamenten: Trägervermittelter Membrantransport

Pharmacokinetics

3.2K Ansichten

article

3.4 : Arzneimittelabsorption: Faktoren, die die gastrointestinale Absorption beeinflussen

Pharmacokinetics

3.4K Ansichten

article

3.5 : Bioverfügbarkeit: Überblick

Pharmacokinetics

2.3K Ansichten

article

3.6 : Faktoren, die die Bioverfügbarkeit beeinflussen: First-Pass-Eliminierung

Pharmacokinetics

5.7K Ansichten

article

3.7 : Bioäquivalenz: Überblick

Pharmacokinetics

849 Ansichten

article

3.8 : Effekt "Erster Durchgang"

Pharmacokinetics

4.7K Ansichten

article

3.9 : Zeitverlauf der Arzneimittelwirkung

Pharmacokinetics

1.8K Ansichten

article

3.10 : Wirkstoffverteilung: Gewebebindung

Pharmacokinetics

2.3K Ansichten

article

3.11 : Physiologische Barrieren

Pharmacokinetics

3.2K Ansichten

article

3.12 : Wirkstoffverteilung: Plasmaproteinbindung

Pharmacokinetics

3.9K Ansichten

article

3.13 : Fächermodelle: Modell mit nur einem Fach

Pharmacokinetics

1.9K Ansichten

article

3.14 : Fächermodelle: Modell mit zwei Fächern

Pharmacokinetics

4.8K Ansichten

See More

JoVE Logo

Datenschutz

Nutzungsbedingungen

Richtlinien

Forschung

Lehre

ÜBER JoVE

Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten